Delivery Order SPE2DR25D1104-SPE2DR26FK973
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on January 5, 2026, for the supply of Aprepitant 40 mg capsules in unit dose packages of 5 units. This is a firm fixed-price delivery order valued at $6,492.22, with an ultimate completion date of January 6, 2026. The work will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. This award was not designated as a set-aside contract and was competitively awarded...
- The Defense Logistics Agency awarded a $2,899.88 delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Aprepitant 125 mg capsules in unit dose packaging (6-count). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 13, 2026. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the parent company Cencora, Inc.'s...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Aprepitant 40 mg capsule unit dose 5-count packages, valued at $10,666.78 with a firm fixed price structure. The contract, awarded on December 23, 2025, with an ultimate completion date of December 24, 2025, represents a non-competitive set-aside delivery order executed through AmerisourceBergen's existing indefinite delivery contract vehicle. The point of performance is located in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,498.37 to AmerisourceBergen Drug Corp for the supply of Aprepitant 40 mg capsules in unit dose packages of five. The contract is a firm fixed price delivery order with an ultimate completion date of December 5, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency awarded a delivery order valued at $1,459.88 to AmerisourceBergen Drug Corp for Aprepitant 40 mg capsule unit dose packages (quantity 5) on July 18, 2025, with completion scheduled for July 21, 2025. This is a firm fixed price delivery order issued under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Aprepitant 80 mg capsule unit dose packages in quantities of six, with a contract ceiling value of $10,700.65. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and the order is scheduled for completion...
- The Defense Logistics Agency awarded a delivery order valued at $9,188.59 to AmerisourceBergen Drug Corp for the supply of Aprepitant 40 mg Capsule Unit Dose packages (5-count) with a firm fixed-price structure. The contract, awarded January 7, 2026, with an ultimate completion date of January 8, 2026, represents a non-set-aside competitive award. The place of performance is located in Conshohocken, Pennsylvania, the company's headquarters. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $3,920.19 to AmerisourceBergen Drug Corp for the supply of Aprepitant 40 mg capsules in unit dose packaging of 5s. This competitive award, executed on April 23, 2025, with an ultimate completion date of April 24, 2025, reflects a firm fixed-price contract type with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from its...
- The Defense Logistics Agency awarded a delivery order valued at $11,086.37 to AmerisourceBergen Drug Corp for the supply of Aprepitant 80 mg capsules in unit dose packaging (six-count). This order was competitively awarded without set-aside designation and carries a firm fixed price contract type, with an ultimate completion date of November 19, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $9,618.63 to AmerisourceBergen Drug Corp for the supply of Aprepitant 80 mg capsules in unit-dose packaging. The contract, executed on November 10, 2025, with an ultimate completion date of November 12, 2025, utilizes a firm fixed price structure with no set-aside designation, indicating competitive award. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- SPE2DR25D1104Indefinite Delivery Contract
- SPE2DR25D1104-SPE2DR26FK973Delivery Order
The Defense Logistics Agency awarded a $3,486.81 delivery order to AmerisourceBergen Drug Corp on January 20, 2026, for the supply of Aprepitant 40 mg capsule unit dose packages in quantities of five. The contract, which is not set-aside, carries a firm fixed price structure and an ultimate completion date of January 21, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under the parent organization Cencora, Inc., which operates the AmerisourceBergen business line. This award derives from a larger Indefinite Delivery Contract vehicle with the Defense Logistics Agency Troop Support Medical (valued at $999,999,999.00 through December 2026) that enables comprehensive pharmaceutical supply to military healthcare systems globally. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp regularly supplies brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support Department of Defense healthcare operations. The aprepitant delivery fulfills ongoing pharmaceutical procurement needs for military treatment facilities and veterans' healthcare programs through this established contract framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 1/19/26 |